ASND
Ascendis Pharma ASNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$13.92B
P/E Ratio
—
EPS
$-4.36
Beta
0.48
52W High
$248.60
52W Low
$124.06
50-Day MA
$227.50
200-Day MA
$204.54
Dividend Yield
—
Profit Margin
-31.70%
Forward P/E
44.44
PEG Ratio
—
About Ascendis Pharma AS
Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
Fundamentals
| Revenue (TTM) | $720.13M |
| Gross Profit (TTM) | $625.22M |
| EBITDA | $-131.41M |
| Operating Margin | 0.96% |
| Return on Equity | -818.00% |
| Return on Assets | -6.86% |
| Revenue/Share (TTM) | $11.88 |
| Book Value | $-3.07 |
| Price-to-Book | 78.13 |
| Price-to-Sales (TTM) | 19.33 |
| EV/Revenue | 17.23 |
| EV/EBITDA | -20.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 42.30% |
| Shares Outstanding | $61.39M |
| Float | $60.88M |
| % Insiders | 0.82% |
| % Institutions | 107.37% |
Analyst Ratings
Consensus ($290.31 target)
3
Strong Buy13
BuyData last updated: 4/7/2026